TI
ORIC icon

Tidal Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Tidal Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$628K Buy
57,977
+375
+0.7% +$3.4K ﹤0.01% 1976
2026
Q1 		$730K Buy
+57,602
New +$654K ﹤0.01% 1658

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tidal Investments's ORIC Position: Q2 2026 in Review

Tidal Investments increased its Oric Pharmaceuticals (ORIC) stake by 0.65% in Q2 2026, buying an estimated $3.4K and bringing the position to 57,977 shares worth $628K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Tidal Investments first reported a position in ORIC in Q1 2026 and has held it in 2 quarters since. The position peaked at $730K in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Tidal Investments held 57,977 shares of Oric Pharmaceuticals worth $628K as of Q2 2026.
  • Tidal Investments bought 375 Oric Pharmaceuticals shares in Q2 2026, an estimated $3.4K.
  • Oric Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1976 holding.
  • Tidal Investments first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Tidal Investments's Oric Pharmaceuticals position peaked at $730K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.